Posted on June 14, 2023

June 14, 2023 – Cala announced today that it launched its next-generation Cala kIQ system, a wearable device that delivers therapy for neurological disorders. The San Mateo, California-based company develops the Cala Trio device for transcutaneous afferent patterned stimulation (TAPS) therapy. Cala designed the Trio device for treating tremor. Its kIQ system delivers therapy for action […]

Posted on March 29, 2023

March 23, 2023–(BUSINESS WIRE)–Cala, the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced meeting the primary endpoint on an interim analysis of a prospective, randomized, controlled study. This study, “RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor” (clinicaltrials.gov NCT05540626), demonstrated that adding TAPS therapy to […]

Posted on March 20, 2023

Praxis Precision Medicines has reported topline data from the Phase IIb Essential1 trial of ulixacaltamide (PRAX-944) to treat essential tremor (ET). The placebo-controlled, randomised, dose range finding, double-blind trial has been designed for assessing the safety, tolerability, and efficacy of once-a-day 60mg or 100mg ulixacaltamide treatment against a placebo after 56 days.

Posted on August 25, 2022

The International Essential Tremor Foundation will bring together experts, scientists, patients, and family members for a day of learning about essential tremor.  Lenexa, Kansas – The first ever Essential Tremor Virtual Education Conference will take place Saturday, October, 29, 2022, from 9 AM to 1 PM (CST). Hosted by the International Essential Tremor Foundation (IETF), […]

Posted on March 1, 2022

BURLINGAME, CA — March 1, 2022 — Cala Health, the bioelectronic medicine leader setting a newstandard of patient care for chronic disease, closed 2021 with significant reimbursement accomplishments for patients. New coding and coverage by commercial and government payors makes it easier for physicians to prescribe and patients to afford Cala Health’s clinically proven treatment […]

Categories: ET News, In the News
Posted on March 25, 2021

(Nature Neuroscience, March 18, 2021) Cannabinoids reduce tremor associated with motor disorders induced by injuries and neurodegenerative disease. Here we show that this effect is mediated by cannabinoid receptors on astrocytes in the ventral horn of the spinal cord, where alternating limb movements are initiated. We first demonstrate that tremor is reduced in a mouse […]

Shaky hands are not a sign of aging. And a shaky head is not a sure sign of Parkinson’s disease. An involuntary shaking of the hands, head, voice, legs or trunk can be a sign of essential tremor (ET). ET is one of the most common movement disorders in the world, and the most common […]

Categories: ET Awareness, ET News
Posted on October 8, 2020

By Daniel Tarsy, M.D. Orthostatic tremor is a relatively rare and typically misunderstood condition in which individuals experience marked trembling of their legs which begins immediately after they stand up. Tremor gradually increases to the point that they are unable to remain standing for more than 10-20 seconds at a time before needing to sit […]

Categories: Coping with ET, ET News
Posted on July 9, 2020

The Coronavirus pandemic has prompted the International Essential Tremor Foundation (IETF) to re-evaluate its education and outreach programs. The main goal of these programs has always been to provide support and information to the essential tremor (ET) community, but now the top priority is to ensure the health and safety of the ET community while […]

Posted on March 5, 2020

Steadiwear has a personal interest in raising the curtain on essential tremor and helping those who have it live a better life. While studying structural engineering at the University of Toronto, co-founder and CEO of Steadiwear Mark Elias visited his family over the winter holidays. As he was having coffee with his grandmother and discussing […]